QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study 期刊论文 AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 卷号: 197 作者:  Liu, Kun;  Song, Yanping;  Xu, Gezhi;  Ye, Jian;  Wu, Zhifeng 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study 期刊论文 AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 卷号: 197 作者:  Liu, Kun;  Song, Yanping;  Xu, Gezhi;  Ye, Jian;  Wu, Zhifeng 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05 Prognostic impact of mutation profiling in patients with stage II and III colon cancer 期刊论文 2016, 卷号: 6, 页码: 24310 作者:  Shen, Yinchen;  Han, Xiaohong;  Wang, Jianfei;  Wang, Shuai;  Yang, Hongying 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 Impact of KRAS, BRAF, PI3K, NRAS gene mutation in stage II-III colon cancer. 期刊论文 2015, 卷号: 33, 期号: 15 作者:  Gui, Lin;  Wang, Jianfei;  Shen, Yinchen;  Qian, Xiaoyan;  Wang, Shuai 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 CRM1 as a new therapeutic target for non-Hodgkin lymphoma 期刊论文 2015, 卷号: 39, 期号: 1, 页码: 38-46 作者:  Han, Xiaohong;  Wang, Jianfei;  Shen, Yinchen;  Zhang, Ningning;  Wang, Shuai 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 CRM1  CRM1 inhibitor  Non-Hodgkin lymphoma   Impact of KRAS, BRAF, PI3K, NRAS gene mutation in stage II-III colon cancer. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20 作者:  Gui, Lin;  Wang, Jianfei;  Shen, Yinchen;  Qian, Xiaoyan;  Wang, Shuai 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Carcinoma Based on Chinese Population 期刊论文 2014, 卷号: 7, 期号: 6, 页码: 795-799 作者:  Han, Xiaohong;  Zhang, Zhishang;  Wu, Di;  Shen, Yinchen;  Wang, Shuai 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/13 Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancer 期刊论文 2013, 卷号: 13, 期号: 2, 页码: 89-97 作者:  Wang, Jianfei;  Yang, Hongying;  Shen, Yinchen;  Wang, Shuai;  Lin, Dongmei 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Colorectal cancer  KRAS  mutation detection  direct sequencing   Oral topotecan: Bioavailability, pharmacokinetics and impact of ABCG2 genotyping in Chinese patients with advanced cancers 期刊论文 2013, 卷号: 67, 期号: 8, 页码: 801-806 作者:  Li, Ning;  Song, Yuanyuan;  Du, Ping;  Shen, Yinchen;  Yang, Jianliang 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/13 Oral topotecan  Chinese  Bioavailability  Pharmacokinetics  ABCG2   GENERATION AND BIOLOGICAL CHARACTER ANALYSIS OF EGFR-TKI RESISTANT CELL LINE 期刊论文 2013, 卷号: 8, 页码: S780-S780 作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Ningning;  Ma, Li;  Tao, Dan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Icotinib  EGFR-TKIs  non-small cell lung cancer  HCC827/IR